MNK Stock Price Today $16.50
Year To Date
The Year To Date (YTD) return is -29.85%.
52 Week Low
The 52 Week Low stock price is 11.65 set on Fri, May 4, 2018 which is 22 days ago.
The current price per share is 41.63% above the 52 week low.
52 Week High
The 52 Week High stock price is $49.12 set on Tue, Jul 25, 2017 which is 305 days ago.
The current price per share is -66.41% below the 52 week high.
All Time High
The All Time High stock price is $134.26 set on Mon, Mar 23, 2015 which is 1,160 days ago.
The current price per share is -87.71% below the all time high.
Mallinckrodt Stock Charts
5 Year Stock Chart
The Mallinckrodt 5 year stock chart shows the historical prices over the previous 60 months.
1 Year Stock Chart
The Mallinckrodt 1 year stock chart shows the historical prices over the previous 12 months.
50 Day Moving Average
The 50 Day Moving Average is at $14.35 which is 14.98% below the stock price of $16.50.
200 Day Moving Average
The 200 Day Moving Average is at 23.37 which is -29.40% below the stock price of $16.50.
MNK Company Profile
Mallinckrodt PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $1.37 Billion.
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
Earnings Per Share
The EPS is $21.80.
Price To Earnings Ratio
The P/E Ratio is 0.76
Mallinckrodt has a relatively low price to earnings ratio compared to the overal S&P 500 average, which is about 25%.
Some investors look for very low p/e stocks with the hopes of investing in an undervalued stock. Of course, this is just one factor to consider.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Mallinckrodt PLC was Tue, Feb 27, 2018.
Since this earnings release 88 days ago, the stock price is up by +1.91%.
The most recent Earnings Release Date was on Tue, May 8, 2018, which was 18 days ago.
Since this earnings date, the stock price is up by +29.11%.
MNK currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.